✦ LIBER ✦

Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantrone

✍ Scribed by Stuart-Harris, R.; Simes, R.J.; Coates, A.S.; Raghavan, D.; Devine, R.; Tattersall, M.H.N.

Book ID: 122757313
Publisher: Elsevier Science
Year: 1987
Weight: 516 KB
Volume: 23
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(87)90320-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone versus doxorubicin in advan

Mitoxantrone versus doxorubicin in advanced breast cancer: A randomized cross-over trial

✍ Neidhart, James A.; Gochnour, Diane; Roach, Ralph W.; Steinberg, Jay A.; Young, 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Second line endocrine treatment of advan

Second line endocrine treatment of advanced breast cancer — a randomized cross-over study of medroxyprogesterone acetate and aminoglutethimide

✍ R. Hultoborn; I. Terje; E. Holmberg; U-B. Wallgren; J. Ranstam; J. Bergh; U. Gla 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A prospective randomized trial of doxoru

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

✍ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea

Randomized cross-over study of patient p

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC

✍ Jensen, Lars Henrik; Osterlind, Kell; Rytter, Carsten 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Advanced breast cancer: A randomized stu

Advanced breast cancer: A randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine

✍ J. A. Green; A. J. Slater; I. R. Campbell; V. Kelly 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 676 KB

Randomized Parallel Study of Doxorubicin

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide as Neoadjuvant Treatment of Patients With Breast Cancer

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 57 KB